Carle Illinois College of Medicine

10/14/2026

What if the path to becoming a physician started with a different way of thinking? 🩺

At Carle Illinois, the secondary application Portfolio invites applicants to express their personal connections to Curiosity, Creativity, and Compassion in a new way. It’s an opportunity to bring individual perspectives to the forefront and an early introduction to how approaches medical education: challenging convention, solving problems creatively, and advancing the future of medicine.

🔶
🔷 University of Illinois Urbana-Champaign | Carle Health

10/09/2026

At Carle Illinois, mentorship goes beyond the classroom. Small class sizes and close relationships with faculty and staff create an environment where students are supported, challenged, and encouraged to grow as future .

🔶
🔷 University of Illinois Urbana-Champaign | Carle Health

10/06/2026

🥼 researchers are investigating why long-term users of anti-HIV drugs are prone to weight gain and other fat-related health complications. The answers may lead to safer care for patients living with HIV, improved drug regimens for those using anti-HIV drugs for prevention, and new insights into cell-based treatments for inflammatory conditions that are prevalent in aging.

🔗 https://medicine.illinois.edu/news/researchers-track-links-between-anti-hiv-drugs-and-body-fat-changes

🔶
🔷 University of Illinois Urbana-Champaign | Carle Health

Carle Illinois College of Medicine Professor Bruce Bunnell has been awarded a $4.16M grant from the National Institutes of Health to investigate why long-term users of anti-HIV drugs are prone to weight gain and other fat-related health complications. 

09/29/2026

A new approach to delivering malaria vaccines is bringing disease prevention closer to under-resourced communities worldwide. 🌎 A winner at the Global Summit 2026, VaxiDermis, aims to address one of global health's most pressing challenges.

helps lead the Global Consortium of Innovation and Engineering in Medicine and its growing impact in building solutions to global health challenges.

🔗

VaxiDermis was created by a student team from Nanyang Technological University (NTU) in Singapore. The new vaccine patch is designed to sustain effectiveness under difficult environmental and healthcare conditions –– a potentially important solution for communities where refrigeration and traine...

09/23/2026

New research by an expert geneticist at could pave the way for improved diagnosis and treatment for patients with a rare genetic disorder of the connective tissue that causes joint instability and often severe pain.
https://medicine.illinois.edu/news/ci-med-geneticist-advances-understanding-of-a-rare-connective-tissue-disorder
🔶
🔷 University of Illinois Urbana-Champaign | Carle Health

Three recent studies led by CI MED Clinical Associate Professor Dr. Christina Laukaitis advance the understanding of hypermobile Ehlers-Danlos Syndrome, a rare connective tissue disorder that causes joint instability and often severe pain. The work could could pave the way for improved diagnosis and...

09/09/2026

A career in medicine can be about more than practicing medicine — it can be about advancing it. 🩺 For first-year student Hannah Pescaru, that opportunity is what drew her to . With engineering seamlessly integrated into the medical school experience, students are equipped to approach medicine from a different perspective and help shape what comes next.

🔶
🔷 University of Illinois Urbana-Champaign | Carle Health

09/03/2026

A breakthrough in pancreatic cancer treatment has roots.

Dr. Martin Burke — a renowned organic chemist, physician, and Illinois chemistry professor — co-founded Revolution Medicines while helping to launch the world’s first engineering-based college of medicine, Carle Illinois College of Medicine.

In a recent Phase 3 clinical trial, Revolution Medicine’s oral drug, daraxonrasib, nearly doubled the median survival for patients with advanced pancreatic cancer, offering more time and more manageable side effects than standard chemotherapy.

Daraxonrasib is a small molecule that acts like a molecular glue and switches off mutant KRAS proteins that are the root of most pancreatic cancers.

“For me, I think seeing something that we helped contribute to actually make an impact in the real world kind of leads to this almost amplified sense of urgency to try to do something important,” Burke said.

09/03/2026

I-L-L! 🔶🔷

08/27/2026

At , the secondary application process offers an early look at the learning experience that follows. Applicants are encouraged to think differently and demonstrate curiosity, creativity, and compassion — qualities that continue to shape how students learn, solve problems, and approach challenges throughout the CI MED curriculum. 🩺

🔶
🔷 University of Illinois Urbana-Champaign | Carle Health

08/25/2026

A new wearable device designed to warn dialysis patients when their access point begins to fail will start pilot testing this fall in Illinois. The noninvasive system uses ultrasound to monitor blood flow at the access point and alert doctors to early signs of trouble. It was developed at the University of Illinois Urbana-Champaign by graduates of Carle Illinois College of Medicine and The Grainger College of Engineering.

➡️ https://medicine.illinois.edu/news/u-of-i-innovation-detects-dialysis-access-failure

🔶
🔷 University of Illinois Urbana-Champaign | The Grainger College of Engineering | Landuyt Center for Entrepreneurship | Carle Health

A University of Illinois spinout company, Auvi Labs, has developed a new wearable device designed to warn dialysis patients when their access point begins to fail. The project started as Li’s senior Capstone Innovation at Carle Illinois College of Medicine, where medical students lead cross-discip...